This is filed to report death.It was reported that a patient presented with mitral regurgitation (mr) and dilated cardiomyopathy.On (b)(6) 2023, transcatheter aortic valve implantation (tavi) was performed with a non-abbott device.Cardiac function did not recover after tavi.It was decided to target the mr with a mitraclip procedure; however, heart failure did not improve and low cardiac output syndrome persisted.On (b)(6) 2023, the patient passed away from cardiogenic shock.No additional information was provided.
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on available information, the cause of the reported death and cardiogenic shock cannot be determined.Additionally, the reported patient effect of death is listed in the instructions for use, and is a known possible complication associated with mitraclip procedures.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
|